{"transactions":[{"id":947018,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":70033,"kind":"person","name":"Sandler Andrew Seth","position":1,"cik":"0001596060","reported_name":"Sandler Andrew Seth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-07T01:00:08.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option will vest in a series of twelve (12) successive substantially equal monthly installments, with the first installment vesting on the one month anniversary of the grant date and continuing to vest monthly thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":2500,"derivative":{"exercise_price":2.18,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001493152-26-000702","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853816/000149315226000702/ownership.xml","form_type":"4"}},{"id":1303565,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":70033,"kind":"person","name":"Sandler Andrew Seth","position":1,"cik":"0001596060","reported_name":"Sandler Andrew Seth","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-14T23:58:37.000Z","date":"2025-01-13","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option will vest in a series of twelve (12) successive substantially equal monthly installments, with the first installment vesting on the one month anniversary of the grant date and continuing to vest monthly thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":5000,"derivative":{"exercise_price":1.38,"expiration_date":"2035-01-12","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001654954-25-000414","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853816/000165495425000414/section16.xml","form_type":"4"}},{"id":1685680,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":70033,"kind":"person","name":"Sandler Andrew Seth","position":1,"cik":"0001596060","reported_name":"Sandler Andrew Seth","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-06T02:01:34.000Z","date":"2024-01-04","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments commencing January 4, 2024."}],"balance_after":10000,"derivative":{"exercise_price":0.6099,"expiration_date":"2034-01-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001654954-24-000296","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853816/000165495424000296/section16.xml","form_type":"4"}},{"id":2061713,"issuer":{"id":90802,"kind":"organization","name":"ALPINE IMMUNE SCIENCES, INC.","symbol":"ALPN"},"owners":[{"id":70033,"kind":"person","name":"Sandler Andrew Seth","position":1,"cik":"0001596060","reported_name":"Sandler Andrew Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2023-01-05T19:32:19.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-fourth (1/4th) of the Shares subject to the Option will vest on January 4, 2024, and one thirty-sixth (1/36th) of the remaining Shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to be a service provider through each such date."}],"balance_after":50000,"derivative":{"exercise_price":7.24,"expiration_date":"2033-01-04","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001626199-23-000025","document":"wf-form4_167296511971794.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1596060/000162619923000025/wf-form4_167296511971794.xml","form_type":"4"}},{"id":2140569,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":70033,"kind":"person","name":"Sandler Andrew Seth","position":1,"cik":"0001596060","reported_name":"Sandler Andrew Seth","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-10-07T21:06:16.000Z","date":"2022-10-06","kind":"grant","acquired":true,"shares":10120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On October 6, 2022, the Reporting Person was granted 10,120 Common Stock restricted units pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan."}],"balance_after":24184,"source":{"system":"sec-edgar","filing":"0001654954-22-013530","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853816/000165495422013530/section16.xml","form_type":"4"}},{"id":2179104,"issuer":{"id":90802,"kind":"organization","name":"ALPINE IMMUNE SCIENCES, INC.","symbol":"ALPN"},"owners":[{"id":70033,"kind":"person","name":"Sandler Andrew Seth","position":1,"cik":"0001596060","reported_name":"Sandler Andrew Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2022-08-18T17:05:11.000Z","date":"2022-08-17","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the shares subject to the option will vest on the one (1)-year anniversary of August 17, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Optionee continuing to be a Service Provider through each such date."}],"balance_after":160000,"derivative":{"exercise_price":8.38,"expiration_date":"2032-08-16","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0000899243-22-029178","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1596060/000089924322029178/doc4.xml","form_type":"4"}},{"id":2210011,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":70033,"kind":"person","name":"Sandler Andrew Seth","position":1,"cik":"0001596060","reported_name":"Sandler Andrew Seth","relationship":{"director":true}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2022-07-08T20:10:26.000Z","date":"2022-07-07","kind":"grant","acquired":true,"shares":8874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 7, 2022, the Reporting Person was granted 8,874 Common Stock restricted units pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan."}],"balance_after":14064,"source":{"system":"sec-edgar","filing":"0001654954-22-009457","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853816/000165495422009457/section16.xml","form_type":"4"}},{"id":2300464,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":70033,"kind":"person","name":"Sandler Andrew Seth","position":1,"cik":"0001596060","reported_name":"Sandler Andrew Seth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2022-04-08T23:15:06.000Z","date":"2022-04-07","kind":"grant","acquired":true,"shares":5190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 7, 2022, the Reporting Person was granted 5,190 Common Stock restricted units pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan."}],"balance_after":5190,"source":{"system":"sec-edgar","filing":"0000905718-22-000566","document":"dermata_fm4apr72022.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853816/000090571822000566/dermata_fm4apr72022.xml","form_type":"4"}},{"id":2444442,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":70033,"kind":"person","name":"Sandler Andrew Seth","position":1,"cik":"0001596060","reported_name":"Sandler Andrew Seth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-06T00:24:51.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments commencing January 3, 2022."}],"balance_after":5000,"derivative":{"exercise_price":1.88,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000905718-22-000054","document":"dermata_fm4jan32022.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853816/000090571822000054/dermata_fm4jan32022.xml","form_type":"4"}},{"id":2600568,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":70033,"kind":"person","name":"Sandler Andrew Seth","position":1,"cik":"0001596060","reported_name":"Sandler Andrew Seth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to Buy)","published_at":"2021-08-17T16:43:40.000Z","date":"2021-08-17","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments commencing September 17, 2021."}],"balance_after":10000,"derivative":{"exercise_price":7,"expiration_date":"2031-08-17","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000905718-21-001102","document":"dermata_fm4aug172021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853816/000090571821001102/dermata_fm4aug172021.xml","form_type":"4"}}]}